Hint mode is switched on Switch off

First Trust NYSE Arca Biotechnology UCITS ETF (USD) (FBTU, IE00BL0L0H60)

(%)
-
NAV Per Share
Exchange Traded Funds (ETF)
Type of fund
Equity
Investment category
Technologies
Sector
USA
Investor locations
27/05/2020
Inception Date
5.85 mln USD
Total assets of the fund
0.6 %
Total Cost Ratio
NYSE Arca Biotechnology Index
Benchmark
First Trust
Provider
5.46 mln USD
Stock class assets
No
Dividend payments
-
Replication method
-
Minimum entry threshold
-
Split
IE00BL0L0H60
ISIN
FBTU
Ticker
CEOGLS
CFI

explore the most comprehensive database

800 000

bonds globally

Over 400

pricing sources

80 000

stocks

9 000

ETF

track your portfolio in the most efficient way
Bond Search
Watchlist
Excel ADD-IN
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Latest data on
Latest data on 14/02/2024
Add element to compare

Quotes (FBTU)

Yield on 13/05/2024

  • YTD
    -5.98 %
  • 1M
    1.64 %
  • 3M
    3.03 %
  • 6M
    12.46 %
  • 1Y
    -2.3 %
  • 3Y
    -
  • 5Y
    -
  • 10Y
    -
At the price on the exchange, taking into account income payments

Price dynamics

Structure on 13/05/2024

Paper Value
Moderna, Inc. 3.87%
Corcept Therapeutics Incorporated 3.8%
Mettler-Toledo International Inc. 3.76%
Amgen Inc. 3.74%
BeiGene, Ltd. (ADR) 3.72%
Biogen Inc. 3.69%
United Therapeutics Corporation 3.69%
Halozyme Therapeutics, Inc. 3.66%
Natera, Inc. 3.54%
Vertex Pharmaceuticals Incorporated 3.52%
Waters Corporation 3.51%
Regeneron Pharmaceuticals, Inc. 3.5%
BioNTech SE (ADR) 3.47%
Incyte Corporation 3.47%
Catalyst Pharmaceuticals, Inc. 3.45%
Alkermes Plc 3.28%
Neurocrine Biosciences, Inc. 3.28%
Alnylam Pharmaceuticals, Inc. 3.27%
Intra-Cellular Therapies, Inc. 3.26%
Genmab A/S (ADR) 3.23%
Gilead Sciences, Inc. 3.22%
Repligen Corporation 3.09%
argenx SE (ADR) 3.08%
Exelixis, Inc. 3.02%
Beam Therapeutics Inc. 3%
ACADIA Pharmaceuticals Inc. 2.87%
Illumina, Inc. 2.87%
BioMarin Pharmaceutical Inc. 2.83%
Bruker Corporation 2.75%
Exact Sciences Corporation 2.53%

Similar ETF & Funds

Other ETF & Funds from this provider

Registration is required to get access.